Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000245257 | SCV000313397 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Center for Pediatric Genomic Medicine, |
RCV000515001 | SCV000610063 | likely benign | not provided | 2017-03-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000515001 | SCV001869599 | benign | not provided | 2019-07-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000515001 | SCV002497401 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | TNXB: BP4, BS1, BS2 |
Genome Diagnostics Laboratory, |
RCV002278203 | SCV002566337 | benign | Ehlers-Danlos syndrome | 2022-05-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418087 | SCV002679499 | benign | Cardiovascular phenotype | 2018-12-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |